What is AXSM's current stock price?

As of now, AXSM is trading at $138.12, with a daily change of +0.52%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AXSM Stock Analysis & IQ Rating | Axsome Therapeutics

AXSM

Axsome Therapeutics

$138.12

+$0.72 | +0.52%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$ 144.15

MKT CAP

$ 6.95B

52W Low

$ 75.56

VOL

$ 33.43K

P/E Ratio

N/A

AVG VOL

$ 516.76K

RSI

61.86

TREND

Uptrend

AXSM Stock IQ

Login to see Axsome Therapeutics (AXSM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AXSM Target Price

Login to display

Strengths

AXSM Rewards

Upgraded on attractively valued

Chart

$127.94 (+7.96%)

$117.14 (+17.91%)

$103.7 (+33.19%)

$99.65 (+38.61%)

1year

6month

3month

1month

AXSM Risk Level

AXSM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

AXSM Analysts Opinion

AXSM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

AXSM Analysts Opinion

AXSM Analysts opinion is negative but has improved from the past 3 months

AXSM Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

38%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

100%

AXSM Street Sentiment

AXSM Street Sentiment is unimpressive and have negative views on the near-term outlook

AXSM Performance Sentiment

Sentiments overview associated with AXSM events and the stock performance.

38%

62%

Positive

Negative

5 out of 13
events present

8 out of 13
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$140.86

Resistance
Price

$124.75

Current Price Range

$140.86

Show methods +

Linked to AXSM

IQ

Close Price

Change

TEVA

4.16

25.17

-1.45%

AXSM Latest Analysis +

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics. Baergic shareholders eligible to receive up to approximately $82 million in potential development regulatory and sales milestones plus a tiered mid-to-high single digit royalty on global net sales from Axsome

Thu Nov 6, 2025

$139.41 | +2.74%

Activity

Needham Reiterates Axsome Therapeutics (AXSM) Buy Recommendation. Fintel reports that on November 4 2025 Needham reiterated coverage of Axsome Therapeutics (NasdaqGM:AXSM) with a Buy recommendation. Analyst Price Forecast Suggests 33.07% Upside

Tue Nov 4, 2025

$134.93 | -0.60%

Rating

Axsome Therapeutics Inc. (NASDAQ:AXSM) Q3 2025 Earnings Call Transcript. Axsome Therapeutics Inc. (NASDAQ:AXSM) Q3 2025 Earnings Call Transcript November 3 2025 Axsome Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.94 EPS expectations were $-0.82. Operator: Good morning and welcome to the Axsome Therapeutics Third Quarter 2025 Earnings Conference Call. My name is Daryl and I will be your operator for today’.s call. [….]

Tue Nov 4, 2025

$134.93 | -0.60%

Earnings

Axsome Therapeutics GAAP EPS of -$0.94 misses by $0.07 revenue of $171M beats by $8.01M.

Mon Nov 3, 2025

$135.75 | +0.56%

Earnings

Earnings Scheduled For November 3 2025. . CNA Financial (NYSE:CNA) is expected to report quarterly earnings at $1.29 per share on revenue of $3.43 billion. . Ryanair Hldgs (NASDAQ:) is expected to report quarterly earnings at $3.62 per share on revenue of $6.42 billion. . Ares Management (NYSE:ARES) is projected to report quarterly earnings at $1.14 per share on revenue of $1.09 billion. . Loews (NYSE:L) is likely to report earnings for its third quarter. . Pediatrix Medical Group (NYSE:MD) is l

Mon Nov 3, 2025

$135.75 | +0.56%

Earnings

Uncovering Potential: Axsome Therapeuticss Earnings Preview. AXSM) is set to give its latest quarterly earnings report on Monday 2025-11-03. Here'.s what investors need to know before the announcement.Analysts estimate that Axsome Therapeutics will report an The announcement from Axsome Therapeutics is eagerly anticipated with investors seeking news of surpassing estimates and favorable guidance for the next quarter.It'.s worth noting for new investors that guidance can be a key determin

Fri Oct 31, 2025

$134.99 | +1.38%

Earnings

Momentum

Axsome Therapeutics (AXSM) May Report Negative Earnings: Know the Trend Ahead of Next Weeks Release. Axsome (AXSM) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mon Oct 27, 2025

$134.68 | +3.96%

Earnings

FAQ About AXSM Stock Insights

What is AXSM current stock price?

What are AXSM stock strengths?

What risks are associated with AXSM stock?

When is AXSM next earnings report?

What is AXSM market cap and volume?

What is AXSM's current Stock IQ?

Should I buy AXSM stock right now?

Is AXSM a Strong Buy right now?

What does a 'Strong Buy' rating mean for AXSM?

What does a 'Strong Sell' rating mean for AXSM?

What factors influence AXSM's Stock IQ?

Explore our AXSM Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AXSM Stock Strategies
Effective Risk Management

FIND US ON

Receive our AXSM Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AXSM

Axsome Therapeutics

Current Price

$138.12

+$0.72 | +0.52%

52W High

$ 144.15

MKT CAP

$ 6.95B

52W Low

$ 75.56

VOL

$ 33.43K

P/E Ratio

N/A

AVG VOL

$ 516.76K

RSI

61.86

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

AXSM Rewards

Upgraded on attractively valued

Linked to AXSM

Symbol

IQ

Close

Change

TEVA

4.16

25.17

-1.45%

AXSM Stock IQ

Login to unlock Axsome Therapeutics (AXSM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$127.94 (+7.96%)

$117.14 (+17.91%)

$103.7 (+33.19%)

$99.65 (+38.61%)

1year

6month

3month

1month

AXSM Analysts Opinion

AXSM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

AXSM Analysts Opinion

AXSM Analysts opinion is negative but has improved from the past 3 months

AXSM Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

38%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

100%

AXSM Street Sentiment

AXSM Street Sentiment is unimpressive and have negative views on the near-term outlook

AXSM Risk Level

AXSM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

AXSM Performance Sentiment

Sentiments overview associated with AXSM events and the stock performance.

38%

62%

Positive

Negative

5 out of 13
events present

8 out of 13
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$140.86

Resistance
Price

$124.75

Current Price Range

$140.86

Show methods +

AXSM Latest Analysis

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics. Baergic shareholders eligible to receive up to approximately $82 million in potential development regulatory and sales milestones plus a tiered mid-to-high single digit royalty on global net sales from Axsome

Thu Nov 6, 2025

$139.41 | +2.74%

Activity

Needham Reiterates Axsome Therapeutics (AXSM) Buy Recommendation. Fintel reports that on November 4 2025 Needham reiterated coverage of Axsome Therapeutics (NasdaqGM:AXSM) with a Buy recommendation. Analyst Price Forecast Suggests 33.07% Upside

Tue Nov 4, 2025

$134.93 | -0.60%

Rating

Axsome Therapeutics Inc. (NASDAQ:AXSM) Q3 2025 Earnings Call Transcript. Axsome Therapeutics Inc. (NASDAQ:AXSM) Q3 2025 Earnings Call Transcript November 3 2025 Axsome Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.94 EPS expectations were $-0.82. Operator: Good morning and welcome to the Axsome Therapeutics Third Quarter 2025 Earnings Conference Call. My name is Daryl and I will be your operator for today’.s call. [….]

Tue Nov 4, 2025

$134.93 | -0.60%

Earnings

Axsome Therapeutics GAAP EPS of -$0.94 misses by $0.07 revenue of $171M beats by $8.01M.

Mon Nov 3, 2025

$135.75 | +0.56%

Earnings

Earnings Scheduled For November 3 2025. . CNA Financial (NYSE:CNA) is expected to report quarterly earnings at $1.29 per share on revenue of $3.43 billion. . Ryanair Hldgs (NASDAQ:) is expected to report quarterly earnings at $3.62 per share on revenue of $6.42 billion. . Ares Management (NYSE:ARES) is projected to report quarterly earnings at $1.14 per share on revenue of $1.09 billion. . Loews (NYSE:L) is likely to report earnings for its third quarter. . Pediatrix Medical Group (NYSE:MD) is l

Mon Nov 3, 2025

$135.75 | +0.56%

Earnings

Uncovering Potential: Axsome Therapeuticss Earnings Preview. AXSM) is set to give its latest quarterly earnings report on Monday 2025-11-03. Here'.s what investors need to know before the announcement.Analysts estimate that Axsome Therapeutics will report an The announcement from Axsome Therapeutics is eagerly anticipated with investors seeking news of surpassing estimates and favorable guidance for the next quarter.It'.s worth noting for new investors that guidance can be a key determin

Fri Oct 31, 2025

$134.99 | +1.38%

Earnings

Momentum

Axsome Therapeutics (AXSM) May Report Negative Earnings: Know the Trend Ahead of Next Weeks Release. Axsome (AXSM) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mon Oct 27, 2025

$134.68 | +3.96%

Earnings

Discover AXSM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AXSM. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AXSM Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AXSM Stock trends

AXSM Stock performance

AXSM Stock analysis

AXSM investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AXSM

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AXSM

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

AXSM Stock Analysis & IQ Rating | Axsome Therapeutics

AXSM Stock IQ

AXSM Target Price

AXSM Risk Level

AXSM Analysts Opinion

AXSM Street Sentiment

AXSM Performance Sentiment

Technical Price Levels

Explore our AXSM Stock insights

Receive our AXSM Daily Alerts

AXSM Stock IQ

AXSM Street Sentiment

AXSM Risk Level

Technical Price Levels

Discover AXSM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of AXSM. We're here to help you make informed investment decisions today.

Receive our AXSM Daily Alerts

AXSM Runner Alarm